Yahoo Search Búsqueda en la Web

Resultado de búsqueda

  1. Febrile neutropaenia (FN) is defined as an oral temperature of >38.3°C or two consecutive readings of >38.0°C for 2 h and an absolute neutrophil count (ANC) of <0.5 × 10 9 /l, or expected to fall below 0.5 × 10 9 /l. incidence, morbidity, mortality and microorganisms.

  2. 12 de sept. de 2022 · FeverFever in neutropenic patients is defined as a single oral temperature of ≥38.3°C (101°F) or a temperature of ≥38.0°C (100.4°F) sustained over a one-hour period . The definition of fever is discussed in greater detail separately.

  3. 26 de nov. de 2022 · Febrile neutropenia (FN) is associated with mortality rates as high as 40%, highlighting the importance of appropriate clinical management in this patient population. The morbidity and mortality of FN can be attributed largely to infectious processes, with specific concern for infections caused by pathogens with antimicrobial resistance.

  4. 2 de feb. de 2024 · This topic will provide an overview of the concepts related to neutropenic fever, including definitions of fever and neutropenia and categories of risk. The risk assessment and diagnostic approach to patients presenting with neutropenic fever are discussed in detail separately.

  5. 1 de mar. de 2021 · Since the introduction of the concept of empiric antibiotic therapy upon the first fever in neutropenic patients, 1 the management of febrile neutropenia has evolved, reflecting changes in the epidemiology of infection, the development of new diagnostic tools and antimicrobial agents, and changes in the treatment of the underlying malignancies.

  6. 26 de nov. de 2022 · Febrile neutropenia (FN) is associated with mortality rates as high as 40%, highlighting the importance of appropriate clinical management in this patient population.

  7. 16 de feb. de 2024 · An overview of neutropenic fever syndromes, the risk assessment of patients with neutropenic fever, the diagnostic approach to patients presenting with neutropenic fever, and the use of colony-stimulating factors in patients with chemotherapy-induced neutropenia are also discussed elsewhere.